Journal of Clinical Apheresis
Publication Venue For
Trends in the use of therapeutic plasma exchange in multiple myeloma
Exclusive use of PowerFlow ports may not be appropriate for all patients
New subcutaneous PowerFlow port results in cost and time-savings in a busy outpatient apheresis clinic
Solving the calcium gluconate shortage in real-time: Mistakes made and lessons learned
Debunking superstition: Analyzing the cloud phenomenon in apheresis—Results of a 35-month study
Do we have enough evidence for recommending therapeutic plasma exchange for patients with natalizumab-associated progressive multifocal leukoencephalopathy?
Therapeutic plasma exchange For Hashimoto's encephalopathy
Hospital-acquired anemia due to diagnostic and therapy-related blood loss in inpatients with myasthenia gravis receiving therapeutic plasma exchange
Increased troponin I is associated with fatal outcome in acquired thrombotic thrombocytopenic purpura
Extracorporeal photopheresis practice patterns: An international survey by the ASFA ECP subcommittee
“Black cloud” vs. “white cloud” physicians – Myth or reality in apheresis medicine?
Establishing an institutional therapeutic apheresis registry
The thrombotic microangiopathy Registry of North America: A United States multi-institutional TMA network
Therapeutic plasma exchange for intractable pruritus secondary to primary sclerosing cholangitis
Apheresis research–more abstracts should be published as full manuscripts to provide more evidence for clinical practice guidelines
Apheresis in developing countries around the World
Extracorporeal photopheresis: Technique, established and novel indications
Out with the bad and in with the good; Red cell exchange, white cell reduction, and platelet reduction
Therapeutic apheresis academy 2013: Beyond borders
Therapeutic plasma exchange rapidly improves cardiac allograft function in patients with presumed antibody-mediated rejection
Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research
Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab
Novel ADAMTS13 mutations in an obstetric patient with Upshaw-Schulman syndrome
Update on extracorporeal photopheresis in heart and lung transplantation
Guidelines on the use of therapeutic apheresis in clinical practice - Evidence-based approach from the apheresis applications committee of the American Society for Apheresis
Is therapeutic plasma exchange indicated for patients with gemcitabine-induced hemolytic uremic syndrome?
Continuous infusion of calcium gluconate in 5% albumin is safe and prevents most hypocalcemic reactions during therapeutic plasma exchange
Category IV indications for therapeutic apheresis - ASFA fourth special issue
Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis
Photopheresis in solid organ transplant rejection.
Altering interface detector positioning in combination with prestorage filtration to achieve a better quality of single donor platelet concentrates using the CS 3000 Plus blood separator
Characteristics of photopheresis treatments for the management of rejection in heart and lung transplant recipients.
Patients with thrombotic thrombocytopenic purpura commonly develop metabolic alkalosis during therapeutic plasma exchange
International Standard Serial Number (issn)
Electronic International Standard Serial Number (eissn)